First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
Clinical trial NCT06121401 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06121401
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2027-03-15
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.